Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide

New England Journal of Medicine

Volumn 353, Issue 1, 2005, Pages 23-32

  Mestan, Karen K L ^a   Marks, Jeremy D ^a   Hecox, Kurt ^a   Huo, Dezheng ^b   Schreiber, Michael D ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PLACEBO;

ANTHROPOMETRY; ARTICLE; BIRTH WEIGHT; BLINDNESS; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISABILITY; DRUG EFFECT; ENCEPHALOMALACIA; EVALUATION; FEMALE; FOLLOW UP; HEARING LOSS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NERVE CELL DIFFERENTIATION; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEX; EDUCATIONAL STATUS; INCIDENCE; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; MENTAL DEFICIENCY; MORTALITY; NEUROPSYCHOLOGICAL TEST; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BLINDNESS; BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; CEREBRAL PALSY; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, BILATERAL; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; LEUKOMALACIA, PERIVENTRICULAR; LINEAR MODELS; MALE; MENTAL RETARDATION; NEUROPSYCHOLOGICAL TESTS; NITRIC OXIDE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; TREATMENT OUTCOME;

EID: 21444434255     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa043514     Document Type: Article

References (29)

1. Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998;179:1632-9.
2. Blaymore-Bier J, Pezzullo J, Kim E, Oh W, Garcia-Coll C, Vohr BR. Outcome of extremely low-birth-weight infants: 1980-1990. Acta Paediatr 1994;83:1244-8.
3. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990's. Early Hum Dev 1999;53:193-218.
4. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-13.
5. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216-26.
6. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003;349:2099-107.
7. Cheung PY, Peliowski A, Robertson CM. The outcome of very low birth weight neonates (
8. Bayley N. Bayley scales of infant development. 2nd ed. San Antonio, Tex.: Harcourt Brace, 1993.
9. Swaiman KF, Russman BS. Cerebral palsy. In: Swaiman KF, Ashwal S, eds. Pediatric neurology: principles and practice. 3rd ed. St. Louis: Mosby, 1999:314.
10. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med 2000;154:725-31.
11. National Center for Health Statistics, Kuczmarski RJ, Ogden CL, et al. 2000 CDC growth charts for the United States: methods and development. Vital and health statistics. Series 11. No. 246. Washington, D.C.: Government Printing Office, 2002:1-190. (DHHS publication no. 2002-1696.)
12. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-6.
13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
14. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001;107:E1.
15. O'Shea TM, Klinepeter KL, Meis PJ, Dillard RG. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants. Paediatr Perinat Epidemiol 1998;12:72-83.
16. Pinto-Martin JA, Riolo S, Cnaan A, Holzman C, Susser MW, Paneth N. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics 1995;95: 249-54. [Erratum, Pediatrics 2001;108:238.]
17. Msall ME, Tremont MR. Functional outcomes in self-care, mobility, communication, and learning in extremely low-birth weight infants. Clin Perinatol 2000;27:381-401.
18. Piecuch RE, Leonard CH, Cooper BA, Sehring SA. Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. Pediatrics 1997;100:633-9.
19. Rubin RA, Balow B. Measures of infant development and socioeconomic status as predictors of later intelligence and school achievement. Dev Psychol 1979;15:225-7.
20. Dezoete JA, MacArthur BA, Tuck B. Prediction of Bayley and Stanford-Binet scores with a group of very low birthweight children. Child Care Health Dev 2003;29:367-72.
21. Doyle LW, Casalaz D. Outcome at 14 years of extremely low birthweight infants: a regional study. Arch Dis Child Fetal Neonatal Ed 2001;85:F159-F164.
22. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-505.
23. Wang X, Tanus-Santos JE, Reiter CD, et al. Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A 2004;101:11477-82.
24. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221-6.
25. Gidday JM, Shah AR, Maceren RG, et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 1999;19:331-40.
26. Zhang YT, Zhang DL, Cao YL, Zhao BL. Developmental expression and activity variation of nitric oxide synthase in the brain of golden hamster. Brain Res Bull 2002;58:385-9.
27. Soyguder Z, Karadag H, Nazli M. Neuronal nitric oxide synthase immunoreactivity in ependymal cells during early postnatal development. J Chem Neuroanat 2004;27:3-6.
28. Sanchez-Islas E, Leon-Olea M. Nitric oxide synthase inhibition during synaptic maturation decreases synapsin I immunoreactivity in rat brain. Nitric Oxide 2004;10:141-9.
29. Van Meurs et al. Inhaled nitric oxide for premature Infants with severe respiratory failure. N Engl J Med 2005;353:13-22.